Reuters logo
8 天前
BRIEF-Aquinox Pharmaceuticals qtrly loss per share $0.59
2017年8月8日 / 中午12点17分 / 8 天前

BRIEF-Aquinox Pharmaceuticals qtrly loss per share $0.59

1 分钟阅读

Aug 8 (Reuters) - Aquinox Pharmaceuticals Inc

* Aquinox Pharmaceuticals announces second quarter 2017 financial results

* Qtrly loss per share $0.59

* Aquinox Pharmaceuticals - ‍continues to expect that its cash-on-hand will carry it beyond top-line data from leadership 301 trial and into 2019​

* Q2 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S

* Aquinox Pharmaceuticals - ‍announcing its plans to initiate a proof-of-concept phase 2 trial with rosiptor (AQX-1125) in patients with CP/CPPS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below